Dr. Jeanine Bussiere is currently Scientific Executive Director of Toxicology at Amgen, having moved after the acquisition of Immunex (July 2002), where she was the Director of Pharmacology/Toxicology for 3 years. Prior to joining Immunex, Dr. Bussiere was a scientist at Genentech for 8 years. Dr. Bussiere is a Diplomate of the American Board of Toxicology, and is a member of the Society of Toxicology, the ILSI/HESI Immunotoxicology Technical Committee, and the American College of Toxicology. She is past President of the Immunotoxicology Specialty Section of SOT. Her expertise is in the area of biotherapeutic drug development and immunotoxicology.